Ángel Cedillo Selected Research

Ángel Cedillo Research Topics

7	COVID-19 01/2024 - 10/2020
4	Neoplasms (Cancer) 10/2023 - 10/2020
2	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 01/2024 - 01/2023
2	Infections 01/2023 - 09/2022
2	Breakthrough Infections 01/2023 - 01/2022
2	Non-Hodgkin Lymphoma (Lymphosarcoma) 09/2022 - 10/2020
1	Coinfection 10/2023
1	Hematologic Diseases (Blood Diseases) 09/2022
1	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 10/2020
1	Hematologic Neoplasms (Hematological Malignancy) 10/2020
1	Aplastic Anemia (Anemia, Hypoplastic) 06/2015

3	Adrenal Cortex Hormones (Corticosteroids)IBA 10/2023 - 09/2022
3	AntibodiesIBA 01/2023 - 01/2022
2	remdesivirIBA 01/2024 - 10/2023
2	nirmatrelvir and ritonavir drug combinationIBA 01/2024 - 10/2023
2	VaccinesIBA 01/2023 - 01/2022
2	COVID-19 VaccinesIBA 01/2023 - 01/2022
2	Monoclonal AntibodiesIBA 09/2022 - 10/2020
1	N-methyl-valyl-amiclenomycin (BA 2)IBA 01/2024
1	N-(2-cyanoethylene)urea (BA 1)IBA 01/2024
1	Immunoglobulin G (IgG)IBA 01/2023
1	Chimeric Antigen ReceptorsIBA 01/2023
1	Antineoplastic Agents (Antineoplastics)IBA 10/2020
1	Antiviral Agents (Antivirals)IBA 10/2020
1	thymoglobulin FDA Link 06/2015
1	Antilymphocyte Serum (Anti-Thymocyte Globulin)IBA 06/2015

4	Cell- and Tissue-Based Therapy (Cell Therapy) 10/2023 - 01/2022
4	Therapeutics 10/2023 - 10/2020
2	Stem Cell Transplantation 01/2024 - 01/2023
1	Drug Therapy (Chemotherapy) 10/2020